Onapsis helped pharmaceutical companies protect their critical ERP, production, and supply chain systems from increasingly sophisticated cyberattacks targeting R&D, clinical trials, and manufacturing. Their solutions safeguarded intellectual property, preventing theft of key research and therapies while reducing business disruptions that could impact product integrity and safety. By addressing the growing risks and compliance demands, Onapsis enabled pharma organizations to minimize costly data breaches, fines, and penalties, ensuring secure and resilient operations in a highly regulated industry.

Join for free to read